GlassScriptPhysician profile
Colleen E Heiby
NPI 1407254162
$4,464.16
in general payments reported to CMS, 2019-2025
21 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,190 · 2022: $1,098 · 2023: $1,449 · 2024: $583 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,176.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,239.72 | 2021-2024 | Fasenra, Airsupra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $617.26 | 2021-2023 | Spiriva Respimat |
| Glaxosmithkline, LLC. | $525.99 | 2021-2023 | Nucala, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $299.07 | 2021-2025 | Cuvitru |
| Abbvie INC. | $237.12 | 2021-2023 | |
| Csl Behring | $202.26 | 2022-2024 | Hizentra, Haegarda |
| Amgen INC. | $186.65 | 2022-2024 | Tezspire |
| Pfizer INC. | $169.03 | 2023 | |
| Octapharma USA, INC. | $168.53 | 2022-2024 | Cutaquig |
| Verona Pharma, INC. | $122.31 | 2025 | Ohtuvayre |
| Genzyme Corporation | $117.64 | 2021-2024 | |
| Optinose US, INC. | $115.80 | 2022-2024 | |
| Kaleo, INC. | $113.61 | 2021-2023 | Auvi-Q |
| Regeneron Healthcare Solutions, INC. | $74.10 | 2021-2024 | Dupixent |
| Insmed, INC. | $57.80 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $52.12 | 2021 | |
| Novartis Pharmaceuticals Corporation | $50.22 | 2021-2023 | |
| Mylan Specialty L.P. | $43.07 | 2021 | |
| Advanced Respiratory, INC | $33.12 | 2021 | |
| Theratechnologies INC. | $20.08 | 2021 | |
| Electromed, INC. | $18.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Heiby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.